Summary. Most toxigenic strains of Clostridium di#iciie produce two toxins : an enterotoxin (toxin A) and a cytotoxin (toxin B). Only one strain (strain 8864) has been reported to produce toxin B but no toxin A. Serogroup F strains (44) of C. dzficile, often isolated from asymptomatic infants, have been examined for toxin production. These strains, which were from distinct geographical and clinical sources, did not produce any detectable toxin A in citro when examined in three distinct immunoassays. Nevertheless, all the strains produced a cytotoxin. Immunological differences between the cytotoxin of the serogroup F strains and that produced by C. dz3ciie strain VPI 10463 (serogroup G) were demonstrated with monoclonal antibodies specific for either the toxin B produced by C . dificiie strain VPI 10463 or C. sordellii lethal toxin (LT). Polymerase chain reaction amplification with primers derived from C. dtficile strain VPI 10463 toxin A and B genes showed that serogroup F strains seem to possess a toxin B gene homologous with that of strain VPI 10463 and at least fragments of the toxin A gene. When axenic mice were inoculated with serogroup F strains, the animals survived; they did not develop diarrhoea and no toxin A could be detected in their faeces. However, cytotoxin was detected. Furthermore, these mice were protected against subsequent challenge with the otherwise lethally toxigenic C . dzflcile strain VPI 10463. The serogroup F strains appeared to be homogeneous and distinct from other C. diflcile strains with regard to toxin production.
Introduction
The aetiological role of Clostridium dificile in pseudomembranous colitis and antibiotic-associated diarrhoea has been clearly demonstrated.'. * Pathogenicity appears to be due mainly to the production of two toxins-an enterotoxin (toxin A) and a cytotoxin (toxin B).3-6 However, there is considerable interstrain variation in the amounts of toxins produced in uitro.i.R Most workers agree that there is a link between toxin A and €3 production, and this is in agreement with the linkage of these toxin genes on the chromosome.9 l o There has been only one strain (strain 8864) identified previously as toxin A-, B + , f 1~1 2
Typing methods based on polyacrylamide gel electrophoresis (PAGE) and serogrouping have been used recently in conjunction, yielding a classification of 21 serogroups of C. dZfi~ile.'~-'~ Some serogroups are homogeneous with regard to toxin production but others include toxigenic and non-toxigenic strains. 8 All strains of serogroup F produced cytotoxin, but toxin A production was not determined. 15 Strains from this serogroup were mainly isolated from asymptomatic infants. l 9 In clindamycin-treated hamsters, Delmke et al. 20 compared the pathological effect of 10 different C. dzflcile serogroups, and found that the reference strain of serogroup F (ATCC 43598) was the only toxigenic strain examined that did not induce colitis, despite producing detectable cytotoxin in the intestine. In this study, serogroup F strains were further characterised with regard to production of toxin A, presence of the toxin A gene, and pathogenicity.
Materials and methods

Strains of C. digiciie
The 44 serogroup F strains were isolated from patients' stools between 1983 and 1991 on CCFA (cycloserin-cefoxitin-fructose-agar) medium and identified by colony morphology and gas-liquid chromatog r a p h~.~~ Their origins are indicated in 
Serogrouping
The serogroup of each strain was determined by slide agglutination with rabbit antisera by the method described by Delmke et al., 14 and confirmed by PAGE as described previo~s1y.l~
Monoclonal and polyclonal antibodies
Monoclonal (MAb) and polyclonal antibodies against toxin A and toxin B of strain VPI 10463 were produced as described MAbs against C. sordellii lethal toxin (LT) were prepared after immunisation of BALB/c Jackson mice with purified toxin LT.24 Fusion was performed with SP20 myeloma cells.21 Two MAbs (N1 and 52) were obtained and characterised in ELISA with pure C. sordellii toxin LT. The ELISA titres against toxin LT were 5.2 log,, and 6.2 log,,, respectively. Both were IgG,, IC antibodies and cross-reacted with purified C. dificile toxin B from strain VPI 10463 in ELISA and immunoblotting.
Detection of C. dificile toxins
Toxin A detection with ELISA. Three distinct sandwich ELISAs were employed. In the first, MAbs and polyclonal antibodies were prepared against toxin A.217 23 Microtitration plates (Immulon Type 1, Dynatech) were coated with the mouse MAb (Cl 1) diluted 1 in 3000 in sodium bicarbonate buffer and incubated overnight at 4°C. Plates were washed with phosphatebuffered saline containing Tween 20 0.1% w/v (PBS-T) and incubated for 90 min at 37°C with three-fold serial dilutions of the toxin-containing sample in PBS-T supplemented with Soybean Trypsin Inhibitor (Sigma) 1 mg/ml. After further washing, rabbit polyclonal antiserum against toxin A was added (1 in 2000 dilution) and the plates were incubated at 37°C for 2 h. They were washed again and incubated with an alkaline phosphatase-labelled anti-rabbit IgG (Sigma) diluted 1 in 2000 in PBS-T for 90 min. After a final wash, enzyme substrate (p-nitrophenyl phosphate, Sigma 104 tablets) in ethanolamine buffer (pH 9.8) was added and the absorbance at 405nm was measured after incubation for 1 h at 37°C. Toxin A concentration was estimated from a standard curve and expressed as log,, ng/ml (culture medium) or log,, ng/g (faeces). 23 The detection limit was 0.1 ng/ml.
The second ELISA with two polyclonal antisera to toxin A from pig and rabbit has been described p r e v i o~s l y .~~ The third ELISA was a commercial system (PREMIER-C. dzficile Toxin A EIA, Meridian Diagnostics Inc.) with MAbs and polyclonal antibodies to toxin A. 25 Toxin B detection. Cytotoxic activity was measured on CHO-K1 cells after three-fold serial dilution of samples.' It was expressed as log,, titre corresponding to the highest dilution causing 100% cell rounding. Neutralisation of cytotoxicity was examined with an anti-C. sordellii and an anti-C. dificile serum (Wellcome, Belgium).
Immunological assays for toxin B
Four MAbs (two raised against C. dificile strain VPI 10463 toxin B, and two raised against C. sordellii LT) were used to further characterise the cytotoxins produced by serogroup F strains in comparison with that produced by strain VPI 10463. Wells of microtitration plates (Immulon type 1, Dynatech) were coated for 2 h at 37°C with serogroup F strain culture supernates obtained after culture for 4 days in dialysis fla&s6 and two-fold serially diluted in carbonate buffer (pH 9.6). The wells were washed and 1 in 100 dilutions of ascites fluid containing antitoxin B or antitoxin LT were added. After incubation for 1 h at 37"C, wells were washed, a 1 in 1000 dilution of anti-mouse peroxidase conjugate was added and the plates were incubated for 2 h at 37°C. The wells were washed and 0.1 ml of tetramethylbenzidine substrate (TMB kit, Dynatech) was added to each well. Reactions were stopped by the addition of 2~ sulphuric acid and the optical densities were measured at 450 nm. All washes were with PBS-T.
D N A amplification by polymerase chain reaction ( P W
Purified DNA (100 ng) was amplified by PCR with synthetic oligonucleotides (table IV) derived from toxin A and B gene nucleotide sequences, respectively.'. 26v 27 DNA amplification was performed in a total volume of 100 pl of 10 mM Tris HCl (PH 8.3) containing 50mM KCl, 4mM MgCl,, bovine serum albumin 0.1 %, 100 p~ deoxynucleotide triphosphates, 10 mM 2-mercaptoethanol, 25 pmol of each primer, and 2.5 U of Taq polymerase (Amersham). Reaction mixtures were denaturated initially at 95°C for 2 min, then subjected to 30 cycles of denaturation (20s at 95"C), annealing (20 s at 68°C for toxin B primers or 52°C for toxin A primers), and extension (20 s at 72°C) in a Prem I11 thermal cycler (Flobio). Amplification products were visualised by ethidium bromide staining after agarose 1 * / o gel electrophoresis.
Animal experiments
Axenic C3He/J mice were reared in a Trexler isolator fitted with a rapid transfer system (La Calhene, Velizy, France) and fed with a rodent diet (R03-40, UAR, Villemoisson, France). All materials introduced into the isolator had been sterilised by irradiation or heating .
Mice received 0.5 ml of a 24-h culture of C. dzficile (10' cfu/ml) by the orogastric route. Population levels in faeces were measured by viable counts on Brain Heart Infusion Agar (BHI, Difco). Faecal toxin levels were estimated as described above. For protection experiments, mice received the highly toxigenic strain VPI 10463 by the orogastric route, 11 days after inoculation of the serogroup F strain. After toxin estimation, and viable counts, C. dzficile colonies from the lowest dilution giving isolated colonies were serotyped by the method described above. This allowed estimation of the relative counts of the serogroup F, and the serogroup G VPI 10463 strains.
Results
The 44 C. dzficile strains were identified as members of serogroup F in slide agglutination and PAGE. Fig.  1 contrasts typical serogroup F PAGE patterns with those of reference strains belonging to serogroup G. Table I shows their origins; most were isolated from asymptomatic infants and a few were from adults. Many were isolated in Belgium (one from Poland) but at different times in various hospitals. They were from 1 1 out-patients and 33 in-patients. The latter were from seven different hospitals and 17 different units, and were, therefore, epidemiologically distinct. Only three of the faecal samples from which they were isolated were liquid, and all three were from children with mild diarrhoea. All 44 strains produced cytotoxin at levels of 2.1-4.5 log,, (average 3.1 log,,) (table 11). Reference strains (lethal for hamster2' or gnotobiotic mice') produce similar levels of toxin B, except the VPI strain which is known to produce high levels of toxin. The cytotoxin was neutralised by both anti-C. dzficile and anti-C. sordellii sera. Toxin A production was not detected in any of the three ELISAs (table 11) for any serogroup F strain. However, the results with reference strains were all positive for toxin A in these tests.
Toxin production is enhanced by dialysis c~l t u r e .~'~ C. dzficile strain VPI 10463 and three serogroup F strains (chosen for their high level of toxin B production) were grown in dialysis culture (table 111) . Toxin A production by strain VPI 10463 was increased. However, no toxin A was detected in serogroup F dialysis cultures.
Immunological epitopes of the toxin B produced were investigated by reaction with four distinct MAbs. The toxin B produced by strain VPI 10463 reacted strongly with the two MAbs raised against C. dzficile toxin B and those raised against C. sordellii LT. By contrast, the toxin B produced by serogroup F strains did not react with MAbs raised against C. dzficile toxin B but reacted with one of the MAbs specific for C. sordellii LT (table 111) .
PCR confirmed the presence of a toxin B gene homologous to that of C. dzficile strain VPI 10463 in the serogroup F strains, at least for the DNA region corresponding to the primers P89-P90 (table IV and   Table 111 . Biological activity and immunological analysis of toxins produced in dialysis culture by three C. dzjicile serogroup F strains and a reference strain of serogroup G fig. 2c ). Serogroup F strains also contained at least the region corresponding to the repeated portion (primers P3 lLP60 ( fig. 2a ) and the 5' terminal sequence (primers P32-P66) of the toxin A gene, (fig. 2b) .1° No amplification products were detected with C . sordellii strain IP 82 which produces a toxin that is immunologically similar. but distinct from, C . dzflcile toxin A ( fig. 2) . Axenic mice were inoculated with strain 33179; fig.  3 shows typical results. The animals did not develop diarrhoea, nor did they die. Toxin B was found in their faeces but no toxin A was detected. Two weeks after inoculation with the serogroup F strain, the mice were challenged with the lethal strain VPI 10463. The mice remained healthy, toxin B titres did not increase and toxin A remained undetectable. At days 3 and 6 postchallenge, selective enumeration showed (/g) lo8 cfu of serogroup F colonies, but < lo6 cfu of serogroup G, Days after inoculation 
Discussion
C. dzficile strains of serogroup F are often isolated from asymptomatic infants and are known to produce toxin B (cytot~xin).'~ Our data suggest that serogroup F strains do not produce toxin A in vitro. They represent a group of toxin A-, B+ strains. Only one other toxin A-, B+ strain has been described (strain 8864) and this was more cytotoxic than strain VPI 10463, in contrast with serogroup F strains which were all less cytotoxic than strain VPI 10463.11*12 PCR amplification indicates that serogroup F strains probably have a toxin B gene homologous to that of the reference
The toxin A gene primers revealed that parts of the 5' terminal sequence and of the repeated region (corresponding to the portion binding to the carbohydrate receptor) are present in serogroup F strains, despite their failure to produce detectable toxin A.1o* 31 The serogroup F strains may be real non-producers of toxin A or could produce a modified toxin. MAbs against the antigens corresponding to the repeated sequences do not react with serogroup F strain supernates, suggesting that toxin A, if produced, does not contain these epitopes. 21 Recent work by Borriello et aZ., 12 with hybridisation and PCR, suggested that strain 8864 (toxin A-, B+) did not have the toxin A gene. However, Lyerly et al., with similar techniques but different primers, found that at least a part of the toxin A gene (5' end) was present in this Cytotoxins produced by serogroup F strains and strain VPI 10463 were both neutralised by an anti-C. dzficile and an anti-C. sordellii serum. However, in immunoassays, the cytotoxin of serogroup F strains did not react with two MAbs specific for the toxin B produced by strain VPI 10463. Nevertheless, serogroup F supernates did react with one of the anti-C. sordellii LT MAbs. These results suggest that the cytotoxins from serogroup F strains and strain VPI 10463 contain different epitopes. Serogroup F cytotoxin may be more similar to C. sordellii cytotoxin than to that of C. dzficile strain VPI 10463.
Hamsters treated with clindamycin or cefoxitin and challenged with serogroup F strains did not show any signs of disease.20 This was confirmed in gnotobiotic mice mono-associated with serogroup F strains (F-33179, F-35010 or ATCC 43598). Cytotoxin was produced in vivo but toxin A was not detected. These results are in agreement with studies in vitro.
The protective effect of colonisation with a serogroup F strain to a challenge with a lethal strain, demonstrated here, has not been documented previously. However, these results are in agreement with the observation that pre-infection with a non-toxigenic strain may protect against symptomatic infection with a toxigenic ~t r a i n .~~-~j No toxin A was detected after the challenge, indicating that strain VPI 10463 did not grow or did not produce toxin A in these conditions. Cytotoxin, present in mice faeces throughout the experiment, did not increase significantly after the challenge. Furthermore. selective C. dzficile enumeration showed that serogroup F strains exercised an antagonistic effect against strain VPI 10463 similar to the effect previously described with two VPI clones.3* The poor detection limit of the colony serogrouping method prevented f i r m conclusions as to whether strain VPI 10463 was completely eliminated or merely suppressed to low population levels in the protected mice. These observations may explain why patients carrying serogroup F strains are asymptomatic.
Several reports have shown that asymptomatic infants may carry C. dzfficile strains that produce toxin A in ritro. Whether toxin A is produced in oiro or not,
